Associated tags: Bloomberg Businessweek, Information technology, Financial Times, GPM, Associated Press, News, Press, Insurance, Real estate investment trust, DOJ, Publication, SCAS, FDA, The Wall Street Journal, Person, Professional Services, Legal, Class Action Lawsuit, Cryptocurrency
Retrieved on:
Tuesday, December 20, 2022
Class Action Lawsuit,
Professional Services,
Legal,
Avaya,
LLP,
Bloomberg Businessweek,
The Wall Street Journal,
NYSE,
Financial Times,
SCAS,
Insurance,
DOJ,
Title 11 of the United States Code,
FDA,
Associated Press,
Press,
News,
AVYA,
Bankruptcy,
Publication,
GPM,
Information technology,
Real estate investment trust,
Investment,
Person,
Security (finance),
Pharmaceutical industry,
Reuters Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Avaya Holdings Corp. (“Avaya” or the “Company”) (NYSE: AVYA ) investors concerning the Company’s possible violations of the federal securities laws.
Key Points:
- Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Avaya Holdings Corp. (“Avaya” or the “Company”) (NYSE: AVYA ) investors concerning the Company’s possible violations of the federal securities laws.
- On August 9, 2022, Avaya released its preliminary third quarter 2022 financial results, reporting sales of $577 million, down 20% year-over-year in constant currency.
- On this news, Avaya’s stock fell $0.51, or 45.5%, to close at $0.61 per share on August 9, 2022, thereby injuring investors.
- Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.
Retrieved on:
Monday, December 19, 2022
Class Action Lawsuit,
Professional Services,
Legal,
LLP,
PHP,
Bloomberg Businessweek,
The Wall Street Journal,
NYSE,
Financial Times,
SCAS,
Insurance,
DOJ,
FDA,
Associated Press,
Press,
News,
Publication,
GPM,
Information technology,
PLDT,
Real estate investment trust,
Investment,
Person,
Security (finance),
Pharmaceutical industry,
Reuters Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of PLDT Inc. (“PLDT” or the “Company”) (NYSE: PHI ) investors concerning the Company’s possible violations of the federal securities laws.
Key Points:
- Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of PLDT Inc. (“PLDT” or the “Company”) (NYSE: PHI ) investors concerning the Company’s possible violations of the federal securities laws.
- On this news, the Company’s share price fell $6.35, or 23.7%, to close at $20.46 per share on December 19, 2022, thereby injuring investors.
- Whistleblower Notice: Persons with non-public information regarding PLDT should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program.
- Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.
Retrieved on:
Friday, December 16, 2022
Class Action Lawsuit,
Professional Services,
Legal,
Press,
SCAS,
NYSE,
Information technology,
Financial Times,
Bloomberg Businessweek,
FDA,
Person,
Associated Press,
News,
Insurance,
Real estate investment trust,
Rite Aid,
DOJ,
The Wall Street Journal,
Investment,
Publication,
GPM,
RAD,
Pharmaceutical industry,
Elixir,
Reuters Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Rite Aid Corporation (Rite Aid or the Company) (NYSE: RAD ) investors concerning the Companys possible violations of the federal securities laws.
Key Points:
- Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Rite Aid Corporation (Rite Aid or the Company) (NYSE: RAD ) investors concerning the Companys possible violations of the federal securities laws.
- On September 29, 2022, Rite Aid announced a $252.2 million charge for the impairment of goodwill related to the Companys pharmacy benefit management (PBM) subsidiary, Elixir.
- Whistleblower Notice: Persons with non-public information regarding Rite Aid should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program.
- Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.
Retrieved on:
Thursday, December 15, 2022
Class Action Lawsuit,
Professional Services,
Legal,
Publication,
National Agency of Petroleum, Natural Gas and Biofuels (Brazil),
Person,
GPM,
Financial Times,
Bloomberg Businessweek,
The Wall Street Journal,
SCAS,
DOJ,
Natural gas,
NYSE,
Biofuel,
FDA,
PBR,
National Agency for Food and Drug Administration and Control,
Real estate investment trust,
Press,
News,
Associated Press,
Information technology,
Insurance,
Pharmaceutical industry,
Reuters,
Petrobras,
Petroleum Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, continues its investigation on behalf of Petrleo Brasileiro S.A. - Petrobras (Petrobras or the Company) (NYSE: PBR ) investors concerning the Companys possible violations of the federal securities laws.
Key Points:
- Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, continues its investigation on behalf of Petrleo Brasileiro S.A. - Petrobras (Petrobras or the Company) (NYSE: PBR ) investors concerning the Companys possible violations of the federal securities laws.
- On this news, Petrobrass stock price $1.01, or 9.9%, to close at $9.13 per share on December 14, 2022, thereby injuring investors.
- Whistleblower Notice: Persons with non-public information regarding Petrobras should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program.
- Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.
Retrieved on:
Wednesday, December 14, 2022
Class Action Lawsuit,
Professional Services,
Legal,
Publication,
National Agency of Petroleum, Natural Gas and Biofuels (Brazil),
Person,
GPM,
Financial Times,
Bloomberg Businessweek,
The Wall Street Journal,
SCAS,
DOJ,
Natural gas,
NYSE,
Biofuel,
FDA,
PBR,
National Agency for Food and Drug Administration and Control,
Real estate investment trust,
Press,
News,
Associated Press,
Information technology,
Insurance,
Pharmaceutical industry,
Reuters,
Petrobras,
Petroleum Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Petrleo Brasileiro S.A. - Petrobras (Petrobras or the Company) (NYSE: PBR ) investors concerning the Companys possible violations of the federal securities laws.
Key Points:
- Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Petrleo Brasileiro S.A. - Petrobras (Petrobras or the Company) (NYSE: PBR ) investors concerning the Companys possible violations of the federal securities laws.
- On this news, Petrobrass stock price fell as much as 12.5% during intraday trading on December 14, 2022, thereby injuring investors.
- Whistleblower Notice: Persons with non-public information regarding Petrobras should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program.
- Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.
Class Action Lawsuit,
Professional Services,
Legal,
Bitcoin,
IPO,
Publication,
Person,
GPM,
Financial Times,
Bloomberg Businessweek,
The Wall Street Journal,
SCAS,
DOJ,
FDA,
Real estate investment trust,
Press,
News,
Associated Press,
Information technology,
Insurance,
Security (finance),
Pharmaceutical industry,
Reuters,
Iris Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Iris Energy Limited (Iris or the Company) (NASDAQ: IREN ) investors concerning the Companys possible violations of the federal securities laws.
Key Points:
- Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Iris Energy Limited (Iris or the Company) (NASDAQ: IREN ) investors concerning the Companys possible violations of the federal securities laws.
- On or about November 17, 2021, Iris conducted its initial public offering (IPO), selling approximated 8.27 million ordinary shares at $28 per share.
- Whistleblower Notice: Persons with non-public information regarding Iris should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program.
- Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.
Retrieved on:
Thursday, December 8, 2022
Legal,
Professional Services,
Publication,
Person,
GPM,
Financial Times,
Bloomberg Businessweek,
The Wall Street Journal,
SCAS,
DOJ,
FDA,
Real estate investment trust,
COVID-19,
Press,
News,
Associated Press,
Information technology,
Insurance,
Pharmaceutical industry,
Reuters Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Veru Inc. (Veru or the Company) (NASDAQ: VERU ) investors concerning the Companys possible violations of the federal securities laws.
Key Points:
- Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Veru Inc. (Veru or the Company) (NASDAQ: VERU ) investors concerning the Companys possible violations of the federal securities laws.
- On this news, Verus stock price fell $8.04, or 53.6%, to close at $6.97 per share on November 10, 2022, thereby injuring investors.
- Whistleblower Notice: Persons with non-public information regarding Veru should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program.
- Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.
Retrieved on:
Thursday, December 8, 2022
Class Action Lawsuit,
Professional Services,
Legal,
Publication,
Person,
GPM,
Financial Times,
Bloomberg Businessweek,
The Wall Street Journal,
SCAS,
DOJ,
Disclosure,
FDA,
Real estate investment trust,
Press,
News,
Associated Press,
Information technology,
Income tax,
Insurance,
Security (finance),
Pharmaceutical industry,
Daktronics,
Reuters Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Daktronics, Inc. (Daktronics or the Company) (NASDAQ: DAKT ) investors concerning the Companys possible violations of the federal securities laws.
Key Points:
- Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Daktronics, Inc. (Daktronics or the Company) (NASDAQ: DAKT ) investors concerning the Companys possible violations of the federal securities laws.
- You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
- On this news, Daktronics share price fell $1.30, or 39.2%, to close at $2.02 per share on December 7, 2022, thereby injuring investors.
- Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.
Class Action Lawsuit,
Professional Services,
Legal,
Publication,
Person,
GPM,
Financial Times,
Bloomberg Businessweek,
The Wall Street Journal,
SCAS,
DOJ,
NYSE,
FDA,
Real estate investment trust,
Press,
News,
Associated Press,
Information technology,
Insurance,
Security (finance),
Renewable energy,
Pharmaceutical industry,
Generac Holdings,
Reuters Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Generac Holdings Inc. (Generac or the Company) (NYSE: GNRC ) investors concerning the Companys possible violations of the federal securities laws.
Key Points:
- Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Generac Holdings Inc. (Generac or the Company) (NYSE: GNRC ) investors concerning the Companys possible violations of the federal securities laws.
- On this news, Generacs stock price fell $3.31, or 1.23%, to close at $264.99 per share on August 1, 2022.
- Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.
- This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Retrieved on:
Tuesday, November 29, 2022
Class Action Lawsuit,
Professional Services,
Legal,
Real estate investment trust,
The Wall Street Journal,
Bloomberg Businessweek,
Foreign Corrupt Practices Act,
LDOS,
Insurance,
Financial Times,
Press,
GPM,
Information technology,
SCAS,
Leidos,
News,
NYSE,
Associated Press,
DOJ,
Person,
Publication,
FDA,
Pharmaceutical industry,
Reuters Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Leidos Holdings, Inc. (Leidos or the Company) (NYSE: LDOS ) investors concerning the Companys possible violations of the federal securities laws.
Key Points:
- Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Leidos Holdings, Inc. (Leidos or the Company) (NYSE: LDOS ) investors concerning the Companys possible violations of the federal securities laws.
- You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
- Whistleblower Notice: Persons with non-public information regarding Leidos should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program.
- Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.
